Next Article in Journal
Synergistic Hypoglycemic Effects of Pumpkin Polysaccharides and Puerarin on Type II Diabetes Mellitus Mice
Previous Article in Journal
Magnetic Polyamide Nanocomposites for the Microextraction of Benzophenones from Water Samples
Article Menu
Issue 5 (March-1) cover image

Export Article

Open AccessReview
Molecules 2019, 24(5), 954;

Inhibitory Effects of (−)-Epigallocatechin-3-gallate on Esophageal Cancer

China-US (Henan) Hormel Cancer Institute, No. 127, Dongming Road, Zhengzhou 450008, Henan, China
Tea Research Institute, Zhejiang University, Hangzhou 310058, China
Ningbo Huangjinyun Tea Science and Technology Co. Ltd., Yuyao 315412, China
National Tea and Tea Product Quality Supervision and Inspection Center (Guizhou), Zunyi 563100, China
Authors to whom correspondence should be addressed.
Academic Editor: Saverio Bettuzzi
Received: 5 February 2019 / Revised: 24 February 2019 / Accepted: 4 March 2019 / Published: 8 March 2019
(This article belongs to the Special Issue Catechins in Human Health)
Full-Text   |   PDF [783 KB, uploaded 8 March 2019]   |  
  |   Review Reports


There is epidemiological evidence showing that drinking green tea can lower the risk of esophageal cancer (EC). The effect is mainly attributed to tea polyphenols and their most abundant component, (−)-epigallocatechin-3-gallate (EGCG). The possible mechanisms of tumorigenesis inhibition of EGCG include its suppressive effects on cancer cell proliferation, angiogenesis, DNA methylation, metastasis and oxidant stress. EGCG modulates multiple signal transduction and metabolic signaling pathways involving in EC. A synergistic effect was also observed when EGCG was used in combination with other treatment methods. View Full-Text
Keywords: tea polyphenols; anticancer; angiogenesis; DNA methylation; metastasis; oxidant stress tea polyphenols; anticancer; angiogenesis; DNA methylation; metastasis; oxidant stress

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Wang, L.-X.; Shi, Y.-L.; Zhang, L.-J.; Wang, K.-R.; Xiang, L.-P.; Cai, Z.-Y.; Lu, J.-L.; Ye, J.-H.; Liang, Y.-R.; Zheng, X.-Q. Inhibitory Effects of (−)-Epigallocatechin-3-gallate on Esophageal Cancer. Molecules 2019, 24, 954.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top